Bristol-Myers Squibb Company
Miniaturized Dystrophins Having Spectrin Fusion Domains and Uses Thereof
Last updated:
Abstract:
Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.
Status:
Application
Type:
Utility
Filling date:
28 Apr 2021
Issue date:
4 Nov 2021